Effect of Smac in combination with cisplatin on esophageal cancer cell line ECA109

Objective: This study was to investigate inhibiting effect of structurally unique Second mitochondria-derived activator of caspase (Smac) in combination with cisplatin on esophageal cancer cell line ECA109. Methods: PcDNA3.1-Smac (ECA109/Smac group), pcDNA3.1 (ECA109/neo group) and PBS (ECA109 or co...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Clin Exp Med
Egile Nagusiak: Hou, Liang, Chen, Kang, Hao, Yingtao, Zhao, Yunpeng, Sun, Qifeng, Zhao, Xiaogang, Peng, Chuanliang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: e-Century Publishing Corporation 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694360/
https://ncbi.nlm.nih.gov/pubmed/26770460
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak